The impact of retractor SPONGE-assisted laparoscopic surgery on duration of hospital stay and postoperative complications in patients with colorectal cancer (SPONGE trial): study protocol for a randomized controlled trial by unknown
STUDY PROTOCOL Open Access
The impact of retractor SPONGE-assisted
laparoscopic surgery on duration of
hospital stay and postoperative
complications in patients with colorectal
cancer (SPONGE trial): study protocol for
a randomized controlled trial
Alice M. Couwenberg1*, Maarten J. P. Burbach1, Anke B. Smits2, Marco Van Vulpen1,
Wilhemina M. U. Van Grevenstein3, Peter G. Noordzij4 and Helena M. Verkooijen5
Abstract
Background: To achieve an adequate visual working field during laparoscopic colorectal surgery without
disturbance of the small intestine, patients are positioned in the Trendelenburg position. This position results in
hemodynamic changes that may increase the risk of cardiopulmonary complications and prolonged hospital stay.
Recently, an intraoperative retractor sponge was introduced as an alternative to the Trendelenburg position during
laparoscopic surgery.
The objective of this trial is to study the impact of the use of an intraoperative retractor sponge on the duration of the
hospital stay and risk of perioperative complications in patients undergoing laparoscopic surgery for colorectal cancer.
Methods/design: The SPONGE trial is a monocenter study and follows the cohort multiple randomized controlled trial
(cmRCT) design. It will be conducted within a multicenter prospective observational cohort of colorectal cancer
patients of all stages, for whom longitudinal clinical data and patient-reported outcomes are collected. Patients within
the cohort, who will undergo laparoscopic surgery for distal colon or rectal cancer, are eligible for inclusion and form a
subcohort. From this subcohort, a 1:1 random sample will be offered to undergo surgery with the use of the retractor
sponge. Patients from the subcohort who are not selected will undergo standard treatment, that is, surgery in the
Trendelenburg position. The primary endpoint is the duration of the postoperative hospital stay. Secondary outcomes
are duration of surgery; intraoperative blood loss and fluid balance; and postoperative body temperature, oxygenation
and complications. Both arms require 94 patients.
Discussion: This study is the first randomized controlled trial to evaluate the effect of sponge-assisted laparoscopic
colorectal surgery in comparison with standard Trendelenburg position on hospital stay and peri- and postoperative
complications. Results of this study will also be relevant for other surgical procedures in the pelvic region. The present
study is the second randomized controlled trial according to the cmRCT design, which is embedded within our
colorectal cancer cohort.
Trial registration number: ClinicalTrials.gov NCT02574013. Registered 27 September 2015.
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Background
Colorectal cancer is the fourth most common cause of can-
cer worldwide with the highest incidence in developed
countries [1]. Surgery is still the cornerstone of curative
colorectal cancer treatment. In the Netherlands, more than
half of the colorectal resections is performed laparoscopic-
ally [2]. In laparoscopic colorectal surgery, a clear view on
the operating field without disturbance of the small intes-
tine in the pelvic region is essential. To achieve this, pa-
tients are positioned in a head down (Trendelenburg)
position, having gravity retract the intestines away from the
pelvic region to obtain a clear working field [3]. The Tren-
delenburg position is associated with hemodynamic in-
stability due to the increased intrathoracic and intracranial
pressure [4–6]. This may complicate anesthetic control
and could potentially cause postoperative airway obstruc-
tion due to laryngeal edema, and a decrease in postopera-
tive lung function [7–9]. Nevertheless, the effects of the
Trendelenburg position on postoperative outcomes, for
example, cardiac and pulmonary complications and hos-
pital stay, are still unclear because alternatives for the
Trendelenburg position have not been available so far.
Recently, the Endoractor™ (CE Kawamoto Corporation,
Osaka, Japan) retractor sponge has been introduced to keep
the small intestine aside and create a proper view during
laparoscopic pelvic surgery while the patient is in a hori-
zontal position. The initial Dutch experience with the re-
tractor sponge comes from a nonrandomized matched
pilot study in which 45 patients underwent sponge-assisted
operations and 45 control patients were operated on while
in the Trendelenburg position [10]. Patients who under-
went sponge-assisted surgery had a shorter hospital stay
compared to those in the Trendelenburg position (5.4 and
7 days, respectively, P = 0.041). Fewer cardiac complications
were observed in the sponge-assisted surgery group com-
pared to the Trendelenburg group, although this difference
was not significant (one patient with heart failure versus
three patients with heart failure and one patient with myo-
cardial infarction, respectively). These results seem promis-
ing; however, confirmation with larger numbers in a
randomized setting is required.
Herein, we present a trial designed to evaluate the ef-
fect of sponge-assisted laparoscopic colorectal surgery
on the duration of hospital stay in comparison with
standard care, that is, surgery in the Trendelenburg
position. In addition, we will assess the impact of sponge-
assisted surgery on postoperative complications, peri-
operative blood loss and fluid balance, operation time, and
postoperative oxygenation and body temperature.
Methods/design
Study design
The SPONGE trial is a monocenter randomized con-
trolled trial conducted within a multicenter observational
prospective cohort of colorectal cancer patients. This pro-
ject is launched as the prospective initiative colorectal can-
cer cohort (Dutch: “Prospectief Landelijk ColoRectaal
carcinoom Cohort” (PLCRC)) and follows the protocol of
the “ProspectIve data CollectioN Initiative on Colorectal
cancer (PICNIC)” (ClinicalTrials.gov: NCT02070146). This
cohort was initiated in 2012 at the University Medical
Center Utrecht (the Netherlands) and includes colorectal
cancer patients of all stages. The cohort follows the “cohort
multiple Randomized Controlled Trial” (cmRCT) design,
which aims to facilitate multiple pragmatic randomized
controlled trials simultaneously [11].
Cohort informed consent procedure
Patients are enrolled in the cohort after a diagnosis of
colorectal cancer. Informed consent for the longitudinal
collection of clinical data is required for inclusion. Add-
itionally, patients may provide optional consents to fill-
out questionnaires on patient-reported outcomes and for
the collection of biomaterials (tumor tissue and blood
sample). Upon enrollment, patients are also asked to
provide “broad consent for randomization,” according to
the staged-informed consent procedure developed for
cmRCT [12]. This means that patients may be randomly
selected for experimental interventions in the future if
eligible for this intervention. These patients will then be
offered this experimental intervention, which they may
accept or refuse. In case of refusal, patients receive
standard care. Only patients who accept the offer will
sign an additional informed consent. Patients who are
eligible for the experimental intervention but who are
not randomly selected will undergo standard care and
will not be informed about the experimental interven-
tion. They will serve as controls and their data are com-
pared to the randomly selected patients who were
offered the intervention.
Patient recruitment
For the present study, patients are enrolled in the cohort at
the Department of Surgery of the St. Antonius Hospital,
Nieuwegein, The Netherlands. Eligible patients meet the
following inclusion criteria: 1) histologically confirmed dis-
tal colon (sigmoid) or rectal cancer, 2) planned for elective
laparoscopic colorectal surgery, 3) performance status
WHO 0 to 2 [13], and 4) broad consent for randomization
(Table 1). Patients with an indication for open colorectal
surgery or emergency colorectal surgery and patients with
an inadequate understanding of the Dutch language in
speech and/or writing are excluded.
Random selection
Participants who meet the inclusion criteria of the
SPONGE trial form a subcohort of eligible patients
(Fig. 1). From this subcohort, patients are randomly
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selected on a 1:1 basis. Randomly selected patients are of-
fered sponge-assisted surgery. Stratified randomization is
performed to take into account participation in other on-
going trials within the cohort, of which the (secondary)
endpoints may interfere with endpoints of the SPONGE
trial. At this moment, patients are stratified according to
whether they received boost radiotherapy in the context of
the RECTAL BOOST study, which is running as a cmRCT
within the cohort (ClinicalTrials.gov: NCT01951521) [14].
In this trial, a randomly selected group of patients with lo-
cally advanced rectal cancer is offered an additional radi-
ation boost prior to standard neoadjuvant chemoradiation.
Stratified randomization, using dedicated software, takes
place at the Imaging Division University Medical Center
Utrecht.
Study specific informed consent procedure
Patients randomly selected to be offered the sponge-
assisted surgery form the intervention group. If these pa-
tients accept the offer, additional informed consent is
signed to undergo sponge-assisted surgery. Patients who
are eligible but who are not randomly selected form the
control group and undergo standard treatment, that is,
surgery in Trendelenburg position. According to the
cmRCT design, patients in the control group will not be
informed about the sponge-assisted surgery intervention
and will not sign additional informed consent.
Blinding
This trial is not blinded. The cmRCT design does not
enable blinding of participants in the intervention arm.
Randomly selected patients will be informed about the
sponge intervention and must accept or refuse the
sponge-assisted surgery. Patients in the control group
are blinded to the fact that they serve as controls in the
SPONGE trial. Investigators and physicians cannot be
blinded to sponge use because operation reports require
indication of the used devices for safety reasons.
Intervention
The intervention group consists of all patients that have
been randomly selected to receive an offer for sponge-
assisted surgery. The sponge will be used only in patients
who have accepted the intervention. The sponge, the
Endoractor™, is a sterile device made of compressed cellu-
lose material, which makes it suitable to fit through a 12-
mm port. When inserted into the abdominal cavity, saline
increases the sponge size approximately nine times and
retracts organs by displacement, weight, and friction. First,
the patient is positioned in the Trendelenburg to allow
sponge positioning. After placement, the patient is reposi-
tioned into a horizontal position. After completion of the
surgery, the sponge can be removed easily through a
12 mm port incision.
No side effects or complications related to sponge use
were reported in a previous study [15] or in the pilot
study. The sponge was tested for potential adverse ef-
fects such as cytotoxicity and intracutaneous reactivity
[15]. No tissue trauma or organ damage due to the
sponge has been reported so far. The retractor sponge is
X-ray detectable in case it was left inside the abdomen.
The center in which the study is performed handles a
Table 1 Inclusion and exclusion criteria for the SPONGE trial
Inclusion criteria Exclusion criteria
Participant in the PLCRC project Indication for open colorectal
surgery
Informed consent obtained
for being offered experimental
interventions within the PLCRC project
Emergency colorectal surgery
Distal colon (sigmoid) or rectum
carcinoma
Inadequate understanding of
the Dutch language in speech
and/or writing
Elective laparoscopic surgery
Performance status WHO 0 to 2
PLCRC, prospective cohort of colorectal cancer patients; WHO, World Health
Organization performance status
Fig. 1 Overview study design and treatment allocation. PLCRC, prospective cohort of colorectal cancer patients; SPONGE trial, randomized
controlled trial for clinical evaluation of an intraoperative retractor SPONGE in laparoscopic colorectal surgery
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strict surgical safety checklist, which includes noting
sponge use, making the chance highly negligible that the
sponge will not be removed from the abdomen. Pres-
ently, the SPONGE trial is being conducted with an ex-
perienced colorectal surgeon who has been working
with the retractor sponge since 2013. In the near future,
other colorectal surgeons will participate. Before partici-
pating in the study, surgeons will have completed a
learning curve of 10 sponge-assisted surgeries.
Standard treatment
The control group consists of eligible patients from the
subcohort who were not randomly selected to receive an
offer of the sponge intervention. During surgery, the
control patients are positioned in the Trendelenburg
position, which is standard care during laparoscopic
colorectal surgery. The surgeon will decide the angle of
the Trendelenburg without a pre-specified angle range.
Aesthetical, surgical, and pre- and post-supportive care
other than the positioning of the patient are not pre-
scribed by this study protocol and are carried out ac-
cording to the standards used in the hospital.
Primary outcome
The primary endpoint of this study is postoperative hospital
stay, defined as days from surgery until discharge. Dis-
charge needs to be approved by a checklist confirmed by
the attending physician. The checklist includes the follow-
ing items: absence of fever (temperature below 38.5 °C); ad-
equate pain management (VAS score below 4); absence of
leukocytosis; passing stool (anally or via stoma); resumption
of normal food intake (no nausea or vomiting); absence of
an active, unstable and untreated cardiac, pulmonary or
surgical complication; and presence of a supportive person
at home at the time of discharge [16, 17].
Secondary outcomes
Secondary endpoints are duration of surgery (minutes),
blood-loss (mL), fluid balance (L), body temperature on
arrival at the recovery room, oxygen therapy at discharge
of the recovery room and postoperative complications
(until 30 days after primary surgery).
Pulmonary complications are defined as respiratory
failure, requiring mechanical ventilation; atelectasis, pleural
effusion, or pneumothorax, as diagnosed on chest radio-
graphs; or pneumonia, based on clinical, laboratory, and
imaging findings combined with initiation of antibiotic
therapy. Cardiac complications are reported as symptoms
of myocardial ischemia and cardiac events, including acute
myocardial infarction, congestive cardiac failure, new-onset
or rapid atrial fibrillation, major arrhythmia, and cardiac ar-
rest. Surgical complications are reported as symptoms of
surgical site infection, anastomotic leakage, postoperative
bleeding, or ileal and early stoma-related complications
(that is, ischemia, stoma retraction, or small bowel obstruc-
tion). All endpoints will be captured from patients’ medical
file, operation, and anesthesia records.
Data collection
Clinical data are being captured from the patients’ elec-
tronic medical files and will be collected in an electronic
database encompassing data of all cohort participants.
In this database, variables are registered under a unique
study number provided to each cohort participant. For
patients in the SPONGE trial, additional clinical infor-
mation, that is, duration of surgery, blood loss, fluid bal-
ance, postoperative body temperature, and oxygen
therapy, will be collected from electronic medical files.
Only the research office of the Imaging Division,
University Medical Center Utrecht, possesses the key to
link study numbers back to patient identifiers. At base-
line, data will be collected on demographics, body mass
index, co-morbidities, tumor characteristics, neoadju-
vant therapy, ASA classification, type of anesthesia, and
surgical procedure.
Sample size
In the previously mentioned pilot study, the hospital stay
in the in the Trendelenburg group was 7.0 days com-
pared to 5.4 days in the sponge-assisted surgery group,
with a standard deviation of 2.04 [10]. To calculate a
sample size, we used a two-sided test with a type I error
of 5 % and power of 80 %. We assumed a difference in
duration of hospital stay of 1 day to be clinically relevant
(5 days in the sponge group versus 6 days in the control
group). Based on a refusal rate of 10 % in the interven-
tion arm, a sample size of at least 82 patients per arm is
needed to confirm this hypothesis. Because hospital stay
generally does not have a Gaussian distribution, we de-
cided to add 15 % in order to adjust the sample size for
analysis with nonparametric tests [18]. Our final sample
size was calculated to be 98 patients per arm.
Statistical analysis
Data will be analyzed according to the intention-to-treat
principle. Differences in continuous outcomes will be
tested using independent samples t-tests or nonparamet-
ric equivalents, depending on the distribution. Chi
squared tests (or Fishers Exact tests) will be used to test
differences in categorical variables. Adjusted analyses
will be performed in case of unbalanced randomization
between the intervention and control arm. A P value of
0.05 is considered significant. Statistical analyses will be
performed using Statistical Package for Social Sciences
(SPSS) software (IBM SPSS Statistics for Windows,
Armonk, NY: IBM Corp.).
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Safety reporting
Within the observational colorectal cancer cohort, ser-
ious adverse events (SAEs) are measured by an annual
questionnaire. For the present study, serious adverse
device events (SADEs) and study-specific SAEs are
measured, including major complications, as an event
within the first 30 days after sponge-assisted surgery
resulting in any serious surgical complications or any
medical event resulting in death or a life threatening
situation. The sponsor will report these events within
15 days after notification. SADEs that result in death
or are life threatening are reported within 7 days after
the responsible investigator has first knowledge of it.
SADEs and SAEs are reported on a Dutch web portal
(www.toetsingonline.nl).
Discussion
The SPONGE trial is the first randomized controlled
trial to evaluate the impact of the use of the retractor
sponge during laparoscopic colorectal surgery on dur-
ation of hospital stay and postoperative complications.
Since no alternative for the Trendelenburg position has
been available, the clinical relevance of the effects related
to this position has never been investigated. Recently, re-
sults of a pilot study suggested that avoidance of the
Trendelenburg position might reduce the postoperative
hospital stay [10]. This effect could potentially be ex-
plained by a more stable perioperative hemodynamic
status, which may make patients less prone to develop
complications. Since this pilot study was a nonrando-
mized retrospective matched analysis, the risk of bias is
considerable. Therefore, a randomized trial is warranted
to estimate an unbiased effect of the Trendelenburg pos-
ition on postoperative complications and hospital stay.
This trial is relevant because the number of (non-)surgi-
cal postoperative complications after colorectal surgery is
substantial and result in a relatively high morbidity and
mortality rate [19, 20]. Even though laparoscopic colorectal
surgery is associated with certain benefits as a shorter hos-
pital stay, less blood loss, and a faster recovery of bowel
function, the risk on postoperative cardiopulmonary com-
plications is not evidently lower than in open surgical pro-
cedure. A systematic review on nonsurgical complications
following laparoscopic or open surgery for colorectal cancer
showed no difference in the risk of pulmonary complica-
tions (pooled analysis for laparoscopy in colon cancer (OR
0.78, 95 % CI 0.53 to 1.13) and in rectal cancer (OR 1.19,
95 % CI 0.74 to 1.90)) [21]. Significantly fewer cardiac ad-
verse events were observed in patients undergoing colec-
tomy, but not in those undergoing rectal surgery (OR 0.28,
95 % CI 0.11 to 0.71 and OR 0.85, 95 % CI 0.41 to 1.71, re-
spectively). This could be a result of the more extensive sur-
gery, longer operation time, and higher risk on overall
postoperative morbidity in rectal surgery [22]. Several
studies presented the effects of the Trendelenburg position
on perioperative cardiopulmonary parameters, but postop-
erative data are lacking [7, 8, 23–26]. Besides, the effect of a
patient’s position as an independent factor is hard to evalu-
ate because the perioperative hemodynamic parameters are
partly influenced by pneumoperitoneum, which is the CO2
gas insufflation in the abdominal cavity [3].
The retractor sponge may provide two additional advan-
tages. In the Trendelenburg position, cephalad excursion
(sliding) of the patient while on the operation table can be
problematic, particularly for obese patients or when the
tables are positioned at steep angles. Sliding can cause
skin and neuropathic injuries and can disturb the surgical
procedure [27, 28]. Some devices used for sliding preven-
tion, such as shoulder braces or headrests, can induce
neuromuscular injuries, particularly brachial plexus injury,
and are therefore not recommended [27]. In sponge-
assisted surgery, patients are operated in horizontal pos-
ition with no risk of sliding. Another potential benefit of a
horizontal position is a more comfortable ergonomic pos-
ition for the surgeon. The retractor sponge allows the sur-
geon to work with laparoscopic instruments in a
horizontal line with the patient, which may reduce tension
in the arms and neck. Unfortunately, we are not able to
investigate these potential ergonomic benefits because this
trial is performed at only one center with extensive experi-
ence in sponge-assisted surgery.
This study uses the cmRCT design. This design aims
to overcome shortcomings of classic RCTs such as slow
recruitment, disappointment bias in patients randomized
to the control arm, and poor generalizability due to en-
rollment of only a small proportion of eligible patients
[14, 29]. Trial recruitment within the PLCRC cohort is
expected to be more efficient because patients are re-
cruited from a large patient cohort, and only patients
randomly selected for the intervention are informed
about the intervention. In popular low risk interven-
tions, such as the one used in the present study, the risk
of disappointment bias or dropout in the control arm,
due to a strong preference for the sponge intervention,
is therefore diminished.
A challenging aspect of the cmRCT design is the fact that
multiple trials are conducted simultaneously within one co-
hort. In patients eligible for multiple trials, interference of
endpoints between trials might occur. As mentioned earlier,
some of the patients eligible for the SPONGE trial will have
participated in the RECTAL BOOST study [14]. Patients
having received the boost intervention potentially have a
higher risk on acute toxicity than patients who undergo
standard chemoradiation [30], which could result in peri-
operative complications and thereby prolonged hospital
stay. In order to balance the number of patients treated
with the experimental boost intervention between both
arms, stratified randomization is required. The main
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advantage of stratified randomization is the systematic bal-
ance of factors, which may influence outcome measures be-
tween treatment groups resulting in trial efficiency,
increased power and less need for (biased) post-hoc analysis
[31]. Furthermore, stratified randomization enables the pos-
sibility to detect potential interactions between the boost
intervention and outcome measures of the SPONGE trial.
On the other hand, the more trials conducted within one
cohort, the more strata required for randomization in every
new trial. This will result in complex trial coordination,
treatment allocation, and trial administration. Having too
much trial-induced strata may result in overstratification.
This could lead to unfilled strata, unequal distribution of
stratification factors, or the need for adjusted analysis
[31–33]. In addition, it is yet unclear if there is such as a
limit in number of interventions per patient within the
cmRCT design. In our cohort, these new methodological
challenges should be taken into account when a new trial
is initiated. In the future, expertise of clinicians will be es-
sential in the design of new cmRCT-based trials because
overlap of endpoints must be considered in an early stage
since this could affect potential recruitment rates and
thereby the succeeding of a trial.
A limitation of this study is that the trial is performed
in a single center by a surgeon experienced with
sponges. In the near future, other centers may partici-
pate, which will enhance the generalizability of the re-
sults. In addition, the trial is performed unblinded. The
pragmatic cmRCT design makes blinding impossible be-
cause information must be provided to randomly se-
lected patients because they have to choose whether
they want to undergo sponge-assisted or standard sur-
gery. Clinicians cannot be blinded because perioperative
use of the sponge must be reported in the operation re-
port for safety reasons. To minimize observer bias in
physicians responsible for discharge of the patients, we
use an objective primary endpoint in the form of a dis-
charge checklist. Both intervention arm and control pa-
tients will be assessed by this checklist provided to
attending physicians. According to the cmRCT design,
patients in the control arm are not aware of the fact that
a sponge intervention is available, which may minimize
disappointment bias.
In conclusion, this trial will evaluate the clinical effects
of sponge-assisted laparoscopic colorectal surgery com-
pared to the standard Trendelenburg positioning. Re-
sults of the trial will be applicable to other institutions
performing laparoscopic colorectal surgery, as well as to
other laparoscopic pelvic procedures that make use of
the Trendelenburg position.
Trial status
The trial started in November 2015 and is currently en-
rolling participants.
Ethics approval
This study will be conducted according to the principles of
the Declaration of Helsinki (64th WMA General Assembly,
Fortaleza, Brazil, October 2013) and in accordance with the
Medical Research Involving Human Subjects Act (WMO),
the Good Clinical Practice guidelines, and this study
protocol. The trial study protocol was approved by a
Dutch institutional review board (“Medical research Ethics
Committees United” (MEC-U)) on 5 December 2014 and
is registered on clinicaltrials.gov under ClinicalTrials.gov
NCT02574013.
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